Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads. (Q41386664)
Jump to navigation
Jump to search
scientific article published on 19 February 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads. |
scientific article published on 19 February 2015 |
Statements
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads (English)
Luca Prosperini
Marco Capobianco
Ruggero Capra
Fabio Buttari
Simonetta Galgani
Claudio Solaro
Carlo Pozzilli
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference